Skip to main content
. 2022 Dec;11(12):1908–1923. doi: 10.21037/gs-22-701

Figure 4.

Figure 4

Survival curve for the BRAFV600E mutation and PTMC recurrence (log rank P=0.222) (A); survival curve for PD-L1 expression and PTMC recurrence (log rank P=0.526) (B). PD-L1, programmed death-ligand 1; PTMC, papillary thyroid microcarcinoma.